Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

17.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

19.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.4K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

202
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
202

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parametric hypothesis testing for pathway based hierarchical structural component models.

Genes & genomics·2026
Same author

Analysis of severity in COVID-19 patients by using longitudinal immune profiles.

iScience·2026
Same author

Enhancing polygenic risk prediction by modeling quantile-specific genetic effects.

Scientific reports·2026
Same author

Optoelectronic Synaptic Transistors Based on Colloidal CdSe Nanowires for Energy-Efficient Neuromorphic Computing.

ACS applied materials & interfaces·2026
Same author

Impact of ACEI/ARB use on COVID-19 mortality in patients with ischaemic heart disease: insights from South Korean National health insurance service data.

BMC infectious diseases·2025
Same author

DeepIMB: Imputation of non-biological zero counts in microbiome data.

Genes & genomics·2025

Related Experiment Video

Updated: Apr 18, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.9K

Practical issues in screening and variable selection in genome-wide association analysis.

Sungyeon Hong1, Yongkang Kim1, Taesung Park2

  • 1Department of Statistics, Seoul National University, Seoul, South Korea.

Cancer Informatics
|January 31, 2015
PubMed
Summary

This study evaluates variable selection methods for high-dimensional genomic data. It identifies the optimal combination of pre-screening and penalized regression for accurate single nucleotide polymorphism (SNP) analysis in genome-wide association studies (GWAS).

Keywords:
genome-wide association studypenalized regressionthe Age-Related Eye Disease Study (AREDS)the Korea Association Resource (KARE)variable selection

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K

Related Experiment Videos

Last Updated: Apr 18, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.9K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K

Area of Science:

  • Genetics
  • Statistical Modeling
  • Bioinformatics

Background:

  • High-dimensional data analysis is crucial for statistical modeling, especially in genome-wide association studies (GWAS).
  • Computational cost and estimation accuracy are key challenges in analyzing ultrahigh-dimensional data like single nucleotide polymorphisms (SNPs).
  • Current GWAS methods often use a two-stage approach: pre-screening followed by penalized regression for variable selection.

Purpose of the Study:

  • To investigate the performance of different pre-screening methods combined with penalized regression techniques.
  • To determine the optimal combination for identifying causal SNPs in quantitative trait genome-wide association studies (GWAS).
  • To evaluate these methods using two real-world GWAS datasets.

Main Methods:

  • Utilized a two-stage variable selection approach.
  • Employed various pre-screening techniques based on P-values and regression coefficients.
  • Applied penalized regression models including ridge, lasso, adaptive lasso, and elastic-net for variable selection.

Main Results:

  • Compared the efficacy of different pre-screening and penalized regression combinations.
  • Assessed performance on quantitative phenotypes using two distinct genome-wide association study (GWAS) datasets.
  • Identified specific combinations that offer superior performance in terms of accuracy and efficiency.

Conclusions:

  • The choice of pre-screening method significantly impacts the performance of penalized regression in GWAS.
  • Certain combinations of pre-screening and penalized regression are more effective for variable selection in ultrahigh-dimensional genomic data.
  • Findings provide guidance for optimizing statistical analysis in genome-wide association studies (GWAS).